Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
Provided By GlobeNewswire
Last update: Aug 14, 2024
Revenue Increased 19% both Sequentially and Year over Year
Operating Expenses Decreased 31%, Marking Eight Consecutive Quarters of
Year Over Year Improvement Due to Successful Cost Cutting Initiatives
